https://www.bluejetconsulting.com/blogRSS for NodeWed, 22 Apr 2026 14:41:15 GMThttps://www.bluejetconsulting.com/post/dr-laurent-d%C3%A9cory-bluejet-consulting-managing-director-joins-aurealis-therapeutics-as-coo622508713ffe98cd54186ce0Sun, 06 Mar 2022 19:19:33 GMTLaurent DECORYhttps://www.bluejetconsulting.com/post/biopharma-grabs-55-new-approvals-in-202161d5e92aba3fde0016fce841Wed, 05 Jan 2022 18:56:32 GMTLaurent DECORYhttps://www.bluejetconsulting.com/post/a-very-happy-new-year-to-our-friends-and-partners61d48ee5361c3700170449bdTue, 04 Jan 2022 18:21:13 GMTLaurent DECORYhttps://www.bluejetconsulting.com/post/how-can-pharma-and-medtech-succeed-with-hybrid-launches6123c5412fcd020015429d4bMon, 23 Aug 2021 16:03:19 GMTLaurent DECORYhttps://www.bluejetconsulting.com/post/engaging-with-patients-a-must-for-medtech60001ed365b5f10017b8073eThu, 14 Jan 2021 10:40:53 GMTLaurent DECORYhttps://www.bluejetconsulting.com/post/curevac-partners-with-bayer-pharma-to-boost-mrna-covid-vaccine60001d304d676700186ecaf2Thu, 14 Jan 2021 10:33:34 GMTLaurent DECORYhttps://www.bluejetconsulting.com/post/happy-new-year-from-bluejet-consulting-to-our-friends-partners-colleagues-and-clients5ff32b5cd3737e00341afe31Mon, 04 Jan 2021 14:55:12 GMTLaurent DECORYhttps://www.bluejetconsulting.com/post/oxford-astrazeneca-s-covid-19-vaccine-a-vital-opportunity-for-emerging-markets5ff329d98fcd0f0017159b34Mon, 04 Jan 2021 14:48:37 GMTLaurent DECORYhttps://www.bluejetconsulting.com/post/covid-has-moved-pharma-medtech-to-omni-channel-for-good-time-to-prepare-a-new-gotomarket-strategy5ff325ac581b450017370b30Mon, 04 Jan 2021 14:32:03 GMTLaurent DECORYhttps://www.bluejetconsulting.com/post/covid-19-to-reshape-r-d-investments-toward-infectious-diseases5ff321863bcfe40017a7b085Mon, 04 Jan 2021 14:16:12 GMTLaurent DECORYhttps://www.bluejetconsulting.com/post/mrna-based-vaccines-a-story-of-immigration-science-and-resilience5fe1def7e0dd0900173d6689Tue, 22 Dec 2020 12:01:08 GMTLaurent DECORYhttps://www.bluejetconsulting.com/post/telehealth-integrated-into-care-mix-by-clinical-teams5fda5980179bc000186bdcd0Wed, 16 Dec 2020 19:10:50 GMTLaurent DECORYhttps://www.bluejetconsulting.com/post/covid-19-vaccine-approval-to-massively-accelerate-mrna-innovation5fda57efffb0f20017ad1685Wed, 16 Dec 2020 18:57:19 GMTLaurent DECORYhttps://www.bluejetconsulting.com/post/healthtech-is-coming-of-age-from-ai-drug-discovery-to-omni-channel-commercialization5fda55efcdcf3900174e9884Wed, 16 Dec 2020 18:52:37 GMTLaurent DECORYhttps://www.bluejetconsulting.com/post/prepare-post-covid-gotomarket-strategy-through-adapted-mix-of-remote-and-customer-facing-activities5fda5461dbd75f0017125581Wed, 16 Dec 2020 18:41:59 GMTLaurent DECORYhttps://www.bluejetconsulting.com/post/amazon-launches-its-online-pharmacy-to-reshape-multi-billion-market5fda512e2b32d600172ec6efWed, 16 Dec 2020 18:30:55 GMTLaurent DECORYhttps://www.bluejetconsulting.com/post/the-end-of-swedish-covid-19-exception5fda477c71fa5000178b53ecWed, 16 Dec 2020 17:48:51 GMTLaurent DECORYhttps://www.bluejetconsulting.com/post/moderna-covid-19-vaccine-94-efficacy-with-easier-storage5fda463f27045f0017590619Wed, 16 Dec 2020 17:42:28 GMTLaurent DECORYhttps://www.bluejetconsulting.com/post/accelerating-healthcare-innovation-throughout-the-pandemic5fda449e1b64b6001740ffdcWed, 16 Dec 2020 17:36:48 GMTLaurent DECORYhttps://www.bluejetconsulting.com/post/how-will-covid-19-vaccines-impact-economic-recovery5fda3f66b6666a00177aa01fWed, 16 Dec 2020 17:14:44 GMTLaurent DECORY